Novocure Other Non Cash Items from 2010 to 2024
| NVCR Stock | USD 12.24 0.56 4.38% |
Other Non Cash Items | First Reported 2014-09-30 | Previous Quarter -6.2 M | Current Value -7.9 M | Quarterly Volatility 2.5 M |
Check Novocure financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Novocure main balance sheet or income statement drivers, such as Depreciation And Amortization of 7.8 M, Interest Expense of 3.2 M or Selling General Administrative of 87.6 M, as well as many exotic indicators such as Price To Sales Ratio of 2.96, Dividend Yield of 0.0 or PTB Ratio of 4.16. Novocure financial statements analysis is a perfect complement when working with Novocure Valuation or Volatility modules.
Novocure | Other Non Cash Items |
Latest Novocure's Other Non Cash Items Growth Pattern
Below is the plot of the Other Non Cash Items of Novocure over the last few years. It is Novocure's Other Non Cash Items historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Novocure's overall financial position and show how it may be relating to other accounts over time.
| Other Non Cash Items | 10 Years Trend |
|
Other Non Cash Items |
| Timeline |
Novocure Other Non Cash Items Regression Statistics
| Arithmetic Mean | 83,930 | |
| Coefficient Of Variation | 12,795 | |
| Mean Deviation | 7,182,093 | |
| Median | 1,001,000 | |
| Standard Deviation | 10,738,450 | |
| Sample Variance | 115.3T | |
| Range | 34.7M | |
| R-Value | (0.83) | |
| Mean Square Error | 38T | |
| R-Squared | 0.69 | |
| Significance | 0.0001 | |
| Slope | (2,000,512) | |
| Total Sum of Squares | 1614.4T |
Novocure Other Non Cash Items History
About Novocure Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Novocure income statement, its balance sheet, and the statement of cash flows. Novocure investors use historical funamental indicators, such as Novocure's Other Non Cash Items, to determine how well the company is positioned to perform in the future. Although Novocure investors may use each financial statement separately, they are all related. The changes in Novocure's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Novocure's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Novocure Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Novocure. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Other Non Cash Items | -23.2 M | -22 M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out the analysis of Novocure Correlation against competitors. To learn how to invest in Novocure Stock, please use our How to Invest in Novocure guide.Note that the Novocure information on this page should be used as a complementary analysis to other Novocure's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Complementary Tools for Novocure Stock analysis
When running Novocure's price analysis, check to measure Novocure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novocure is operating at the current time. Most of Novocure's value examination focuses on studying past and present price action to predict the probability of Novocure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novocure's price. Additionally, you may evaluate how the addition of Novocure to your portfolios can decrease your overall portfolio volatility.
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |
Is Novocure's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Novocure. If investors know Novocure will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Novocure listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.06) | Earnings Share (1.95) | Revenue Per Share 4.787 | Quarterly Revenue Growth 0.042 | Return On Assets (0.12) |
The market value of Novocure is measured differently than its book value, which is the value of Novocure that is recorded on the company's balance sheet. Investors also form their own opinion of Novocure's value that differs from its market value or its book value, called intrinsic value, which is Novocure's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Novocure's market value can be influenced by many factors that don't directly affect Novocure's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Novocure's value and its price as these two are different measures arrived at by different means. Investors typically determine if Novocure is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Novocure's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.